Navigation Links
Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
Date:3/29/2013

Ras Al Khaimah, UAE (PRWEB) March 29, 2013

Grace Century, FZ LLC, specializing in “game-changing” life science and health related private equity projects, recently announced the appointment of Yeow Fook (Eddie) Leong to their Advisory Board as Chief Compliance Officer. Leong brings decades of leadership, problem solving, and project leadership experience from Exxon Mobile.

Leong holds his Bachelors of Engineering from the University of Tokyo and is fluent in 5 languages. His international experience--which spans across 4 continents--along with his deep management background, has given him a keen vision of thinking “outside the box.”

Leong’s responsibilities with Grace Century will include due-diligence of potential new projects, ongoing oversight of accepted projects, and marketing coordination of existing projects in Asia and emerging markets. Like Grace Century, Leong will also take an equity participation in all projects, furthering his desire to bring all of Grace Century’s projects full-circle.

Grace Century President, Scott Wolf says, “I have yet to work with anyone who brings in the kind of energy, determination, and pragmatic stance that Eddie Leong brings to our process. He is truly an asset to Grace Century.”

Wolf further adds, “Eddie Leong realizes that all projects have benchmarks that must be met. When these benchmarks are met, they are then further analyzed to determine the areas that can be improved upon. And if these benchmarks are not met, an investigation and analytical review is conducted to determine why--so that alternative (better) steps can be quickly introduced. Simply put: Failure is never an option with Eddie Leong.”

###

About Grace Century
Grace Century, FZ LLC is an international research and private equity consulting company located in Ras Al Khaimah, United Arab Emirates (UAE). Grace Century specializes in conducting due-diligence for its group of international members, as well as assisting firms in the development and execution of “game changing” ideas in the life sciences and healthcare technology industries. Utilizing its vast network, Grace Century assists in capital formation, market penetration, joint ventures, and brand development.

Read the full story at http://www.prweb.com/releases/GraceCenturynews2013/03/prweb10572909.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
5. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
6. Agendia Signs Contract with Blue Shield of California
7. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
8. Volition Signs Collaboration Agreement With Abcodia
9. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
10. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 Aviva ... tools, announced the acquisition of GenWay Biotech Incorporated, ... comprehensive service and product offering for both the ... will facilitate growth and enhance capabilities for both ... and ELISA assays will nicely complement ASB,s objective ...
(Date:2/22/2017)...  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company ... products for companion animals, will host a live conference call ... discuss financial results from the fourth quarter and full year ... investors may access the audio webcast or use ... ...
(Date:2/22/2017)...  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Biocom Global Life Science Partnering Conference.  The presentation will ... the Torrey Pines Lodge, in San Diego.  ... who have chosen our company, amongst numerous others, to ... and clinical researchers," said Mr. Chen. "In contrast to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... development of precision treatments for neurodegenerative diseases, today announced it has issued a ... approach.” This is one of a series of commentaries from ProMIS’s scientific team ...
Breaking Biology Technology:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
Breaking Biology News(10 mins):